Synthetic and Natural Caffeine on Hemodynamic Parameters in Young, Healthy Volunteers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-16

Study Completion Date

2020-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study determine the difference in hemodynamic effects of synthetic and natural caffeine consumption in healthy individuals through blood pressure (central and peripheral) assessment. Participants will randomly be assigned to consume either one 8oz cup of coffee containing 400mg of caffeine (increased caffeine using concentrated coffee) or one 8oz cup of coffee-flavored drink with approximately 400mg synthetic caffeine from capsules dissolved in it.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Energy Drinks on Cardiovascular Endpoints

NCT01329679

Healthy Volunteers

TERMINATED NA

Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults

NCT04060225

High Blood Pressure

TERMINATED NA

Evaluation of Energy Drink Consumption on ECG and Hemodynamic Parameters in Young Healthy Volunteers

NCT02023723

Hemodynamic Effects of Energy Drink Electrocardiograph Effects of Energy Drinks

COMPLETED NA

Post-Exercise Cardiovascular Responses Following Energy Drink Consumption

NCT03418077

QTc Interval

COMPLETED NA

Arrhythmic Effects of Hight Dose Caffeine

NCT02045992

Arrhythmia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to assess the difference in effects of consuming synthetic versus natural caffeine on hemodynamic parameters in healthy subjects. This study will determine the difference in hemodynamic effects of synthetic and natural caffeine consumption in healthy individuals through blood pressure (central and peripheral) assessment. The participants in this study are healthy adults who will be introduced to a risk that may be more than they would encounter through their normal daily activities. This study seeks to add to the literature by evaluating the difference in impact of synthetic compared to natural caffeine on central blood pressure.

This protocol has the following aims:

1. Investigators hypothesize there will be a (baseline adjusted \[ΔBP\]) difference in BP (peripheral and central) between the natural and synthetic caffeine arms in healthy volunteers post consumption.
2. Investigators hypothesize there will be (baseline adjusted \[ΔCO\]) no difference in CO between the natural and synthetic caffeine arms in healthy volunteers post consumption.
3. Investigators hypothesize there will be (baseline adjusted \[ΔSVR\]) no difference in SVR between the natural and synthetic caffeine arms in healthy volunteers hours post consumption.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This protocol uses a crossover design. The subject sample is randomized. Subjects will serve as their own controls as they will be asked to intake both the natural and synthetic caffeine at two different occasions.

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Natural Caffeine

Subjects will be their own control and will have repeated measures after the consumption of a drink with 400mg of natural caffeine. Blood pressure measurements will be taken at baseline, then hourly for four hours.

Group Type EXPERIMENTAL

Natural Caffeine

Intervention Type DIETARY_SUPPLEMENT

Consumption of 400mg of natural caffeine

Synthetic Caffeine

Subjects will be their own control and will have repeated measures after the consumption of a drink with 400mg of synthetic caffeine. Blood pressure measurements will be taken at baseline, then hourly for four hours.

Group Type EXPERIMENTAL

Synthetic Caffeine

Intervention Type DIETARY_SUPPLEMENT

Consumption of 400mg of synthetic caffeine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Natural Caffeine

Consumption of 400mg of natural caffeine

Intervention Type DIETARY_SUPPLEMENT

Synthetic Caffeine

Consumption of 400mg of synthetic caffeine

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy males and females
* Active duty military service members
* DoD beneficiaries
* Participants must be willing to refrain from caffeine use 72 hours prior to study days one and five

Exclusion Criteria

* Cardiovascular risk factors: Heart rhythm other than normal sinus, history of atrial or ventricular arrhythmia, family history of premature sudden cardiac death before the age of 60, left ventricular hypertrophy, acute myocardial ischemia, atherosclerosis, hypertension, and palpitations. This will be determined through the questionnaire responses of the participant and thorough chart review.
* Blood pressure at initial screening appointment or at baseline on study Day One greater than 130/80 and if 130-139/80-89, FRS risk greater than 10%.
* Presence of any known medical condition, confirmed through participant interview up to the discretion of the research team. Examples of these are:
* Hypertension
* Thyroid disease
* Type 1 or 2 Diabetes Mellitus
* Recurrent headaches
* Any psychiatric condition or neurological disorder including seizures
* History of alcohol or drug abuse in the previous five years
* Ever been diagnosed or told they have or had renal or hepatic dysfunction
* Tobacco use
* Concurrent use of any medication taken in an amount greater than twice a week, to include herbal products or supplements, not to include hormonal contraceptives. If less than or equal to two days per week, the investigator will determine if the subject is to be included or excluded based on the available literature for that medication.
* Pregnant or lactating females will be excluded from participation with urine dipstick tests used to rule out pregnancy (pregnancy test performed before each treatment session, days one, five)
* All non-English speaking/writing subjects and those that do not understand the study or consent process will be excluded from the study due to unavailability of medical qualified translator at all times during the study.
* If the subject refuses to sign the informed consent document or HIPAA Authorization, they will be excluded as well.
* Allergy to any substance in the study design.
* Any other medical reason that at the discretion of the investigators would pose a risk to the health of the subject.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes